Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline

BACKGROUND: Carcinoma of the esophagus is an aggressive malignancy with an increasing incidence. Its virulence, in terms of symptoms and mortality, justifies a continued search for optimal therapy. A clinical practice guideline was developed based on a systematic review investigating neoadjuvant or...

Descripción completa

Detalles Bibliográficos
Autores principales: Malthaner, Richard A, Wong, Rebecca KS, Rumble, R Bryan, Zuraw, Lisa
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522817/
https://www.ncbi.nlm.nih.gov/pubmed/15447791
http://dx.doi.org/10.1186/1471-2407-4-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522817/
https://www.ncbi.nlm.nih.gov/pubmed/15447791
http://dx.doi.org/10.1186/1471-2407-4-67

Ejemplares similares